Found 8 matching trials
Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)
PHASE1The purpose of the study is to determine the safety and tolerability of the...
Location
University Of California Medical Center
Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
NAThis is an extension study of Protocol CA194002 to allow 2 specific partici...
Location
Princess Margaret Cancer Centre
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
PHASE1The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Location
Karmanos Cancer Institute
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
PHASE1The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Location
City Of Hope National Medical Center
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
PHASE1The purpose of this study is to evaluate the tolerability and safety profil...
Location
Local Institution
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
PHASE1The purpose of this study is to determine the safety of BMS-833923 (XL139) ...
Location
Mayo Clinic Rochester
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
PHASE1To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic...
Location
City Of Hope National Medical Center
Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
PHASE2The purpose of the study is to compare response rates in newly diagnosed Ch...
Location
John Theurer Cancer Center